603 related articles for article (PubMed ID: 30880230)
1. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
Thomas VM; Brown RM; Ashcraft DS; Pankey GA
Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230
[TBL] [Abstract][Full Text] [Related]
2. Synergistic activity of polymyxin B combined with vancomycin against carbapenem-resistant and polymyxin-resistant Acinetobacter baumannii: first in vitro study.
Shinohara DR; Menegucci TC; Fedrigo NH; Migliorini LB; Carrara-Marroni FE; Maria Dos Anjos M; Cardoso CL; Nishiyama SAB; Tognim MCB
J Med Microbiol; 2019 Mar; 68(3):309-315. PubMed ID: 30663954
[TBL] [Abstract][Full Text] [Related]
3. Non-polymyxin-based combinations as potential alternatives in treatment against carbapenem-resistant Acinetobacter baumannii infections.
Mohd Sazlly Lim S; Naicker S; Ayfan AK; Zowawi H; Roberts JA; Sime FB
Int J Antimicrob Agents; 2020 Oct; 56(4):106115. PubMed ID: 32721600
[TBL] [Abstract][Full Text] [Related]
4. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J
J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752
[TBL] [Abstract][Full Text] [Related]
5. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
[TBL] [Abstract][Full Text] [Related]
6. Comparative metabolomics reveals key pathways associated with the synergistic activity of polymyxin B and rifampicin combination against multidrug-resistant Acinetobacter baumannii.
Zhao J; Han ML; Zhu Y; Lin YW; Wang YW; Lu J; Hu Y; Tony Zhou Q; Velkov T; Li J
Biochem Pharmacol; 2021 Feb; 184():114400. PubMed ID: 33387481
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic Effects of Sulbactam/Meropenem/Polymyxin-B Combination Against Extremely Drug Resistant
Menegucci TC; Fedrigo NH; Lodi FG; Albiero J; Nishiyama SAB; Mazucheli J; Carrara-Marroni FE; Voelkner NMF; Gong H; Sy SKB; Tognim MCB
Microb Drug Resist; 2019 Nov; 25(9):1266-1274. PubMed ID: 31216222
[No Abstract] [Full Text] [Related]
8. In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.
Yoon J; Urban C; Terzian C; Mariano N; Rahal JJ
Antimicrob Agents Chemother; 2004 Mar; 48(3):753-7. PubMed ID: 14982760
[TBL] [Abstract][Full Text] [Related]
9. Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies.
Rao GG; Ly NS; Bulitta JB; Soon RL; San Roman MD; Holden PN; Landersdorfer CB; Nation RL; Li J; Forrest A; Tsuji BT
J Antimicrob Chemother; 2016 Nov; 71(11):3148-3156. PubMed ID: 27494922
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria.
Chi H; Holo H
Curr Microbiol; 2018 Mar; 75(3):272-277. PubMed ID: 29058043
[TBL] [Abstract][Full Text] [Related]
11. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.
Jahangiri A; Neshani A; Mirhosseini SA; Ghazvini K; Zare H; Sedighian H
Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
[TBL] [Abstract][Full Text] [Related]
14. Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility.
Abbey T; Vialichka A; Jurkovic M; Biagi M; Wenzler E
Microbiol Spectr; 2022 Jun; 10(3):e0054222. PubMed ID: 35647655
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii.
Rao GG; Ly NS; Diep J; Forrest A; Bulitta JB; Holden PN; Nation RL; Li J; Tsuji BT
Int J Antimicrob Agents; 2016 Sep; 48(3):331-6. PubMed ID: 27449542
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases.
Wareham DW; Bean DC
Ann Clin Microbiol Antimicrob; 2006 Apr; 5():10. PubMed ID: 16630352
[TBL] [Abstract][Full Text] [Related]
17. The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest and time-kill assay.
Pankey GA; Ashcraft DS
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):228-32. PubMed ID: 19150711
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of Myrtus communis L. essential oils and conventional antibiotics against multi-drug resistant Acinetobacter baumannii wound isolates.
Aleksic V; Mimica-Dukic N; Simin N; Nedeljkovic NS; Knezevic P
Phytomedicine; 2014 Oct; 21(12):1666-74. PubMed ID: 25442275
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore.
Lim TP; Tan TY; Lee W; Sasikala S; Tan TT; Hsu LY; Kwa AL
J Antibiot (Tokyo); 2009 Dec; 62(12):675-9. PubMed ID: 19876075
[TBL] [Abstract][Full Text] [Related]
20. Biogenic silver nanoparticle (Bio-AgNP) has an antibacterial effect against carbapenem-resistant Acinetobacter baumannii with synergism and additivity when combined with polymyxin B.
Allend SO; Garcia MO; da Cunha KF; de Albernaz DTF; da Silva ME; Ishikame RY; Panagio LA; Nakazaro G; Reis GF; Pereira DB; Hartwig DD
J Appl Microbiol; 2022 Feb; 132(2):1036-1047. PubMed ID: 34496109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
